Use of artificial intelligence and machine learning (AI/ML) in drug discovery and development has seen a rapid rise in the past few years, and that progress has been leveraged for the COVID-19 pandemic as well. Two of the leading developers of vaccines against SARS-CoV-2 have used it in their own efforts, and experts and industry insiders are already thinking about how to apply the technology in future pandemics.
The recent AI Cures Drug Discovery Conference ended with a panel discussion on new directions for drug discovery in COVID-19....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?